_id
690daf68ccc777a4e85d0b01
Ticker
AONCW
Name
American Oncology Network Inc
Exchange
NASDAQ
Address
14543 Global Parkway, Fort Myers, FL, United States, 33913
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.aoncology.com
Description
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Last Close
0.78
Volume
32600
Current Price
1.5
Change
15.384615384615383
Last Updated
2025-11-28T12:16:36.199Z
Image
data:image/webp;base64,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
Ipo Date
2021-05-13T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
490884000
Cost Of Revenue
448355000
Gross Profit
42529000
Operating Expenses
482539000
Operating Income
8345000
Interest Expense
1587000
Pretax Income
2333000
Net Income
1316000
Eps
0.048327755015299075
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
1.6999942960047587
Total Other Income Expense Net
-5169000
Cash
62849000
Short Term Investments
9791000
Receivables
129233000
Inventories
60712000
Total Current Assets
331472000
Property Plant Equipment
98531000
Total Assets
470328000
Payables
170736000
Short Term Debt
-
Long Term Debt
87123000
Total Liabilities
362321000
Equity
18771000
Depreciation
5522000
Change In Working Capital
-2738000
Cash From Operations
11926000
Capital Expenditures
6326000
Cash From Investing
-
Cash From Financing
48711000
Net Change In Cash
43417000
PE
-
PB
2.1760211762825636
ROE
7.010814554365777
ROA
0.2798047320168053
FCF
5600000
Fcf Percent
0.011407990482476512
Piotroski FScore
4
Health Score
38
Deep Value Investing Score
5.5
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
7.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
490884000
Quarters > 0 > income Statement > cost Of Revenue
448355000
Quarters > 0 > income Statement > gross Profit
42529000
Quarters > 0 > income Statement > operating Expenses
482539000
Quarters > 0 > income Statement > operating Income
8345000
Quarters > 0 > income Statement > interest Expense
1587000
Quarters > 0 > income Statement > pretax Income
2333000
Quarters > 0 > income Statement > net Income
1316000
Quarters > 0 > income Statement > eps
0.048327755015299075
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
27230729
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
1.6999942960047587
Quarters > 0 > income Statement > total Other Income Expense Net
-5169000
Quarters > 0 > balance Sheet > cash
62849000
Quarters > 0 > balance Sheet > short Term Investments
9791000
Quarters > 0 > balance Sheet > receivables
129233000
Quarters > 0 > balance Sheet > inventories
60712000
Quarters > 0 > balance Sheet > total Current Assets
331472000
Quarters > 0 > balance Sheet > property Plant Equipment
98531000
Quarters > 0 > balance Sheet > total Assets
470328000
Quarters > 0 > balance Sheet > payables
170736000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
87123000
Quarters > 0 > balance Sheet > total Liabilities
362321000
Quarters > 0 > balance Sheet > equity
18771000
Quarters > 0 > cash Flow > net Income
1316000
Quarters > 0 > cash Flow > depreciation
5522000
Quarters > 0 > cash Flow > change In Working Capital
-2738000
Quarters > 0 > cash Flow > cash From Operations
11926000
Quarters > 0 > cash Flow > capital Expenditures
6326000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
48711000
Quarters > 0 > cash Flow > net Change In Cash
43417000
Quarters > 0 > ratios > PE
0.048327755015299075
Quarters > 0 > ratios > PB
2.1760211762825636
Quarters > 0 > ratios > ROE
7.010814554365777
Quarters > 0 > ratios > ROA
0.2798047320168053
Quarters > 0 > ratios > FCF
5600000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.011407990482476512
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
470279000
Quarters > 1 > income Statement > cost Of Revenue
433746000
Quarters > 1 > income Statement > gross Profit
36533000
Quarters > 1 > income Statement > operating Expenses
468484000
Quarters > 1 > income Statement > operating Income
1795000
Quarters > 1 > income Statement > interest Expense
1874000
Quarters > 1 > income Statement > pretax Income
-1560000
Quarters > 1 > income Statement > net Income
-1069000
Quarters > 1 > income Statement > eps
-0.08088968667088545
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13215529
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
0.3816883169352661
Quarters > 1 > income Statement > total Other Income Expense Net
-2118000
Quarters > 1 > balance Sheet > cash
19432000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
128011000
Quarters > 1 > balance Sheet > inventories
49266000
Quarters > 1 > balance Sheet > total Current Assets
271230000
Quarters > 1 > balance Sheet > property Plant Equipment
91015000
Quarters > 1 > balance Sheet > total Assets
394811000
Quarters > 1 > balance Sheet > payables
155494000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
87633000
Quarters > 1 > balance Sheet > total Liabilities
340722000
Quarters > 1 > balance Sheet > equity
-38840000
Quarters > 1 > cash Flow > net Income
-1069000
Quarters > 1 > cash Flow > depreciation
4629000
Quarters > 1 > cash Flow > change In Working Capital
-35993000
Quarters > 1 > cash Flow > cash From Operations
-28079000
Quarters > 1 > cash Flow > capital Expenditures
6452000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-1307000
Quarters > 1 > cash Flow > net Change In Cash
-14386000
Quarters > 1 > ratios > PE
-0.08088968667088545
Quarters > 1 > ratios > PB
-0.5103834577754892
Quarters > 1 > ratios > ROE
2.752317198764161
Quarters > 1 > ratios > ROA
-0.27076246609137034
Quarters > 1 > ratios > FCF
-34531000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.0734266254712628
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
433982000
Quarters > 2 > income Statement > cost Of Revenue
404589000
Quarters > 2 > income Statement > gross Profit
29393000
Quarters > 2 > income Statement > operating Expenses
441327000
Quarters > 2 > income Statement > operating Income
-7345000
Quarters > 2 > income Statement > interest Expense
1833000
Quarters > 2 > income Statement > pretax Income
-3270000
Quarters > 2 > income Statement > net Income
3621000
Quarters > 2 > income Statement > eps
0.26830476071638926
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13495847
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-1.6924665078275134
Quarters > 2 > income Statement > total Other Income Expense Net
4883000
Quarters > 2 > balance Sheet > cash
33818000
Quarters > 2 > balance Sheet > short Term Investments
21391000
Quarters > 2 > balance Sheet > receivables
125421000
Quarters > 2 > balance Sheet > inventories
54280000
Quarters > 2 > balance Sheet > total Current Assets
306262000
Quarters > 2 > balance Sheet > property Plant Equipment
93119000
Quarters > 2 > balance Sheet > total Assets
430762000
Quarters > 2 > balance Sheet > payables
189483000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
88241000
Quarters > 2 > balance Sheet > total Liabilities
376911000
Quarters > 2 > balance Sheet > equity
25002000
Quarters > 2 > cash Flow > net Income
3621000
Quarters > 2 > cash Flow > depreciation
4674000
Quarters > 2 > cash Flow > change In Working Capital
-35253000
Quarters > 2 > cash Flow > cash From Operations
-33927000
Quarters > 2 > cash Flow > capital Expenditures
4044000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-5486000
Quarters > 2 > cash Flow > net Change In Cash
-41126000
Quarters > 2 > ratios > PE
0.26830476071638926
Quarters > 2 > ratios > PB
0.8096860451163906
Quarters > 2 > ratios > ROE
14.482841372690187
Quarters > 2 > ratios > ROA
0.8406033958427159
Quarters > 2 > ratios > FCF
-37971000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.08749441221064468
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
364339000
Quarters > 3 > income Statement > cost Of Revenue
354948000
Quarters > 3 > income Statement > gross Profit
9391000
Quarters > 3 > income Statement > operating Expenses
383225000
Quarters > 3 > income Statement > operating Income
-18886000
Quarters > 3 > income Statement > interest Expense
1763000
Quarters > 3 > income Statement > pretax Income
-22116000
Quarters > 3 > income Statement > net Income
-7841000
Quarters > 3 > income Statement > eps
-0.758703610562207
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10334734
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-5.1836339233516044
Quarters > 3 > income Statement > total Other Income Expense Net
-2260000
Quarters > 3 > balance Sheet > cash
74944000
Quarters > 3 > balance Sheet > short Term Investments
30105000
Quarters > 3 > balance Sheet > receivables
132300000
Quarters > 3 > balance Sheet > inventories
44288000
Quarters > 3 > balance Sheet > total Current Assets
323963000
Quarters > 3 > balance Sheet > property Plant Equipment
84355000
Quarters > 3 > balance Sheet > total Assets
421921000
Quarters > 3 > balance Sheet > payables
188329000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
80856000
Quarters > 3 > balance Sheet > total Liabilities
365813000
Quarters > 3 > balance Sheet > equity
-102460000
Quarters > 3 > cash Flow > net Income
-7841000
Quarters > 3 > cash Flow > depreciation
4546000
Quarters > 3 > cash Flow > change In Working Capital
53616000
Quarters > 3 > cash Flow > cash From Operations
45137000
Quarters > 3 > cash Flow > capital Expenditures
4132000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-254000
Quarters > 3 > cash Flow > net Change In Cash
46405000
Quarters > 3 > ratios > PE
-0.758703610562207
Quarters > 3 > ratios > PB
-0.15129905328908844
Quarters > 3 > ratios > ROE
7.652742533671677
Quarters > 3 > ratios > ROA
-1.858404772457403
Quarters > 3 > ratios > FCF
41005000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.11254628244574422
Quarters > 3 > health Score
32
Valuation > metrics > PE
0.048327755015299075
Valuation > metrics > PB
2.1760211762825636
Valuation > final Score
100
Valuation > verdict
49.8% Undervalued
Profitability > metrics > ROE
7.010814554365777
Profitability > metrics > ROA
0.39701694260752035
Profitability > metrics > Net Margin
0.0026808777633819804
Profitability > final Score
16
Profitability > verdict
Weak
Risk > metrics > Debt Equity
19.302168238239837
Risk > metrics > Interest Coverage
5.258349086326402
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.9414300440446068
Liquidity > metrics > Quick Ratio
1.5858401274482241
Liquidity > final Score
99
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
90
Prev Valuations > 2
50
Prev Profitabilities > 0
6
Prev Profitabilities > 1
34
Prev Profitabilities > 2
15
Prev Risks > 0
34
Prev Risks > 1
-10
Prev Risks > 2
-13
Prev Liquidities > 0
94
Prev Liquidities > 1
90
Prev Liquidities > 2
93
Updated At
2026-01-20T21:23:39.153Z
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAmerican Oncology Network Stock Sees Short Interest Uptick on Nasdaq Composite - Kalkine Media
6/16/2025
American Oncology Network Stock Sees Short Interest Uptick on Nasdaq Composite Kalkine Media
Read more →(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of American Oncology Network Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.